The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click ...

A Comprehensive, Evidence-Based Review of GLP-1/GIP Agonists for Fitness and Wellness ProfessionalsGilbert, AZ, Feb. 12, 2025 (GLOBE NEWSWI ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...

The blockbuster drug semaglutide, better known as Ozempic for diabetes and Wegovy for obesity, could also help people cut down on their alcohol intake, according to new USC research.

Over the past nine years, patients with spinal muscular atrophy have seen the number of FDA-approved treatment options for ...